NRC Health Form 8-K Summary
Business Context and Reporting Period
This Current Report (Form 8-K) covers events occurring on June 23, 2026, regarding NRC Health's 2026 Annual Meeting of Stockholders. The filing details the ratification of corporate governance amendments and the results of six stockholder proposals.
Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on corporate governance and voting results rather than financial performance.
Material Changes and Governance Actions
Stockholders approved amendments to the Company's Certificate of Incorporation and Bylaws, effective June 24, 2026. Key changes include:
- Removal of certain supermajority voting requirements.
- Removal of restrictions on the removal of directors without cause.
- Change in the voting requirement for stockholder action by written consent from unanimous to the standard meeting threshold.
Voting Results and Management Commentary
The following proposals were voted on at the Annual Meeting:
- Election of Directors: All seven nominees (Paul Bhandari, Donald M. Berwick, Trent Green, Michael D. Hays, Stephen H. Lockhart, John N. Nunnelly, and Penny A. Wheeler) were elected. Notably, John N. Nunnelly received the highest "Against" vote count (796,250).
- Ratification of Auditors: KPMG LLP was ratified as the independent registered public accounting firm for 2026.
- Executive Compensation: The advisory vote on named executive officer compensation was approved, though it received significant opposition with 2,894,973 "Against" votes.
- Charter Amendments: Proposals to remove supermajority voting requirements, delete restrictions on director removal, and adjust written consent voting thresholds were all approved.
Key Facts for Investor Verification
- Verify the specific language of the Amended and Restated Certificate of Incorporation (Exhibit 3.1) and Bylaws (Exhibit 3.2) to understand the new governance framework.
- Review the Definitive Proxy Statement filed on May 8, 2026, for detailed context on the executive compensation proposal which faced notable dissent.
- Monitor future filings for financial performance data, as this 8-K contains no operational or financial metrics.